tacrolimus ointment 0.1%

DRUG6 trials

Sponsors

Children´s Clinic, Randers, Astellas Pharma Inc, Fougera Pharmaceuticals Inc., Glenmark Pharmaceuticals Ltd. India, Hospital de Clinicas de Porto Alegre

Conditions

Atopic DermatitisDermatitis, AtopicEczema, AtopicOral Erosive Lichen Planus

Phase 1

Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus

RecruitingNCT06591884

Hospital de Clinicas de Porto AlegreOral Erosive Lichen Planus

Start: 2024-09-03End: 2028-12-31Target: 46Updated: 2024-10-02

Phase 2

Distribution of Tacrolimus in Skin, Atopic Dermatitis

CompletedNCT00534508

Astellas Pharma IncDermatitis, Atopic

Start: 2000-12-31End: 2001-07-31Updated: 2014-09-18

Phase 3

Long-term Safety of Protopic in Atopic Eczema

CompletedNCT00560378

Astellas Pharma IncDermatitis, Atopic, Eczema, Atopic

Start: 1998-06-30End: 2005-06-30Updated: 2014-09-18

Study of 0416 Ointment in the Treatment of Atopic Dermatitis

CompletedNCT01053247

Fougera Pharmaceuticals Inc.Atopic Dermatitis

Start: 2008-01-31End: 2009-08-31Updated: 2014-10-03

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

CompletedNCT02601703

Glenmark Pharmaceuticals Ltd. IndiaAtopic Dermatitis

Start: 2015-08-31End: 2016-10-31Updated: 2019-07-31

Phase 4

Short Term Growth in Children With Atopic Dermatitis

CompletedNCT00236106

Children´s Clinic, RandersAtopic Dermatitis

Start: 2005-02-28End: 2005-06-30Target: 20Updated: 2005-12-09